Physician profile
Dureshahwar Ali
NPI 1578192480
$2,746.70
in general payments reported to CMS, 2019-2025
21 companies · $901 in 2025
The $901 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $451 · 2023: $491 · 2024: $904 · 2025: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,722 · Education: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,722.38 |
| Education | $573.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $489.19 | 2023-2025 | Ensite, Mitraclip |
| Novartis Pharmaceuticals Corporation | $330.85 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $272.19 | 2023-2025 | Lifevest |
| Endotronix, INC. | $222.81 | 2025 | Cordella Pulomonary Artery Pressure Sensor, Cordella Pulmonary Artery Pressure Sensor |
| Janssen Pharmaceuticals, INC | $183.35 | 2023-2024 | Xarelto |
| Boston Scientific Corporation | $177.66 | 2022 | |
| Medicure Pharma INC. | $153.13 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $140.09 | 2024-2025 | Farxiga, Brilinta |
| Amgen INC. | $120.32 | 2022 | |
| United Therapeutics Corporation | $104.40 | 2025 | |
| Abiomed | $98.04 | 2025 | |
| Medtronic, INC. | $81.14 | 2023 | Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.43 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $55.17 | 2024-2025 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $49.35 | 2024 | Arcalyst |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $49.03 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $47.91 | 2023-2025 | Uptravi, Opsumit |
| Pfizer INC. | $35.00 | 2025 | |
| Kestra Medical Technology Services, INC. | $26.53 | 2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $19.35 | 2023 | |
| Exact Sciences Corporation | $13.76 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dureshahwar Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.